Alpha Tau Medical Ltd. (DRTS) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Alpha Tau Medical Ltd. in 2026. The next earnings report is expected on November 24, 2026.
Next earnings date
24 Nov 2026
In 95 days
EPS estimate
-0.14
Revenue estimate
368.3K
Past earnings
Latest earnings analysis
Alpha Tau Medical Ltd. missed consensus estimates in its latest earnings, with EPS of -$0.50 coming in below the -$0.1409 estimate and revenue of $0 falling 100.0% short of the $144.5 thousand projection. The previous report likewise had both EPS and revenue come in below expectations.
No dividend history available.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
Alpha Tau Medical Ltd. (DRTS) is scheduled to report earnings on November 24, 2026.
Alpha Tau Medical Ltd. (DRTS) last reported earnings on August 10, 2026.
Alpha Tau Medical Ltd. (DRTS) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.